Professor shabir madhi
Madhi: Moving SA to level 1 the right move
Vaccinology expert Professor Shabir Madhi said that there was little reason for higher restrictions in the country, especially for those who were vaccinated.
-
Madhi: We vaccinate people to prevent them ending up in hospital
On numerous occasions, the National Health Department has stressed that the vaccines used in the country are safe.
-
Run-up to polls more of a concern for COVID than election day - Prof Madhi
Professor Shabir Madhi said in the case that the Constitutional Court was unable to postpone this year's elections, campaigning would have to be severely limited to prevent COVID-19 casualties reaching new record highs.
-
Health experts urge govt to ramp up COVID-19 vaccinations as infections soar
There’s been a surge in COVID -19 cases in South Africa, with over 8,000 infections recorded over the last 24-hour cycle, while 127 people have succumbed to the virus.
-
Madhi: SA's COVID response was decent, but vaccine rollout a disaster
During a webinar hosted by PSG Konsult, vaccinologist Shabir Madhi rated South Africa's response to the COVID-19 pandemic globally. He said where we fell far short was the rollout of the vaccine in the country. #Vaccines #COVID19news
-
Novavax vaccine offers protection against COVID-19 variants found in SA, UK
The executive director of the Wits Vaccines and Infectious Diseases Analytics Research Unit, Professor Shabir Madhi, said that an updated analysis of the Novavax vaccine trial in South Africa showed vaccine efficacy of 55.4% against mainly mild COVID-19 among HIV-negative trial participants.
-
South Africa likely to miss herd immunity target: scientist
Vaccinology professor, Shabir Madhi, lead investigator on the Oxford/AstraZeneca vaccine trial in South Africa, said the local variant and a third wave of infections expected later this year were likely to hinder inoculation plans.
-
SA should include Novavax in its COVID-19 vaccine arsenal - Madhi
In a local Phase 2b clinical trial, the Novavax vaccine has shown a 60% efficacy in preventing mild, moderate and severe COVID-19 in HIV-negative participants. The vaccine also showed efficacy against the 501Y.V2 coronavirus variant, according to Professor Shabir Madhi.
-
SA's AstraZeneca vaccine rollout on hold; J&J vaccine effective against variant
On Sunday evening, 8 February 2021, Health Minister Zweli Mkhize held a webinar with experts to update the nation on COVID-19 vaccines in South Africa. #COVID19news #AstraZeneca #Vaccines
-
It would be reckless for SA to discard AstraZeneca vaccines - Mahdi
The rollout of that particular vaccine has been put on ice for the time being after early data showed that the AstraZeneca inoculation gave minimal protection against mild-to-moderate infection caused by the dominant variant.
-
SA considering inoculations with 2 different COVID-19 vaccines - Madhi
Wits University professor, Shabir Madhi, said that studies on this method were already under way in the United Kingdom.
-
Novavax COVID-19 vaccine effective against variants identified in SA, UK - Madhi
Data shows the vaccine has a 60% efficacy for the prevention of mild, moderate and severe COVID-19 in 92% of the cohort that was HIV-negative.
-
Oxford/AstraZeneca's COVID-19 vaccine best suited for Africa - Wits' Madhi
The first peer-reviewed results of phase 3 human trials show that the Oxford/AstraZeneca vaccine candidate has an acceptable safety profile and is effective against symptomatic COVID-19.
-
South Africa fears virus comeback as cluster outbreaks flare
The national number of new daily cases crept over 3,000 last week, up 50% from an average of 2,000 earlier in November. More than half the increase is driven by infections in the Eastern Cape and around 25% by cases in the Western Cape.
-
Prof Shabir Madhi: SA must address root cause of flare-up in COVID-19 infections
The professor’s comments come in the wake of coronavirus infection surges in parts of the country, which have raised fears that South Africa could see a second wave in cases compounded by gatherings during the upcoming festive season.
-
The COVID-19 vaccine: 'SA is at the bottom of the queue'
The recent success of vaccine trials has provided some global hope of beating COVID-19. But when will South Africans be able to get their hands on it? We spoke to the country's top scientists to find.
-
SA set for long wait for COVID-19 vaccine as roll out takes shape
Countries like the United States will ensure its citizens are catered to first, while the rest of us will have to wait a little longer to be protected from the coronavirus, which has infected more than 55 million people around the world and claimed the lives of more than 1.3 million others.
-
SA COVID-19 resurgence no surprise for Prof Mahdi, says citizens complacent
Scientists have noticed that complacency and super spreader events are some of the key drivers in the second wave gripping Europe, which is once again the epicentre of the coronavirus pandemic and they're calling on South Africans to learn from Europe's mistakes.
-
SA can learn from Europe's COVID-19 second wave, say experts
Several countries have gone into yet another lockdown to stop the spread of the virus like in Austria, Belgium, Germany, France, Italy and Spain, many of which have fewer coronavirus cases than South Africa at the moment.
